Innate Pharma SA (IPHYF)
2.20
0.00 (0.00%)
USD |
OTCM |
May 09, 16:00
Innate Pharma Total Liabilities (Quarterly): 146.24M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 146.24M |
| June 30, 2023 | 153.43M |
| June 30, 2023 | 153.43M |
| December 31, 2022 | 164.84M |
| June 30, 2022 | 171.41M |
| June 30, 2022 | 171.41M |
| December 31, 2021 | 181.22M |
| June 30, 2021 | 157.86M |
| June 30, 2021 | 157.86M |
| December 31, 2020 | 186.27M |
| June 30, 2020 | 140.92M |
| June 30, 2020 | 140.92M |
| December 31, 2019 | 206.05M |
| June 30, 2019 | 194.76M |
| June 30, 2019 | 194.76M |
| December 31, 2018 | 324.84M |
| June 30, 2018 | 160.42M |
| June 30, 2018 | 160.42M |
| December 31, 2017 | 202.83M |
| June 30, 2017 | 203.02M |
| June 30, 2017 | 203.02M |
| Date | Value |
|---|---|
| December 31, 2016 | 206.58M |
| June 30, 2016 | 237.10M |
| June 30, 2016 | 237.10M |
| December 31, 2015 | 255.71M |
| June 30, 2015 | 264.59M |
| June 30, 2015 | 264.59M |
| December 31, 2014 | 19.53M |
| June 30, 2014 | 25.17M |
| June 30, 2014 | 25.17M |
| December 31, 2013 | 21.54M |
| June 30, 2013 | 26.51M |
| June 30, 2013 | 26.51M |
| December 31, 2012 | 32.97M |
| June 30, 2012 | 38.78M |
| June 30, 2012 | 38.78M |
| December 31, 2011 | 43.37M |
| June 30, 2011 | 19.24M |
| December 31, 2010 | 19.28M |
| June 30, 2010 | 18.08M |
| December 31, 2009 | 24.45M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
140.92M
Minimum
Jun 2020
206.05M
Maximum
Dec 2019
168.09M
Average
164.84M
Median
Dec 2022
Total Liabilities (Quarterly) Benchmarks
| DBV Technologies SA | 42.80M |
| Cellectis SA | 249.58M |
| PHAXIAM Therapeutics SA (DELISTED) | -- |
| Genfit SA | 117.09M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 203.61M |
| Shareholders Equity (Quarterly) | 57.37M |
| Debt to Equity Ratio | 0.7525 |
| Current Ratio | 3.734 |
| Net Debt Paydown Yield | 0.31% |